T50-2017 Discontinuing development of Discovery Studio LigandFit

Dear BIOVIA Customer,

BIOVIA is announcing the discontinuation of development of the Discovery Studio LigandFit small molecule ligand docking engine.

Discovery Studio contains three native small molecule ligand docking engines: LibDock, LigandFit and CDOCKER (CHARMM Docker). In contrast to the physics-based CDOCKER engine, both LigandFit and LibDock serve similar roles for high-throughput virtual screening. To better serve our customers, it is our intention to consolidate our docking approaches to one high-throughput engine (LibDock) and one physics-based engine (CDOCKER). Consequently, we have taken the decision to cease development of the LigandFit docking engine.

The 2017 R2 release (December 2016) is the last version of Discovery Studio LigandFit. Per BIOVIA’s support lifecycle policies, we will continue to provide mainstream support for this docking engine until December 2019 and legacy support will end in December 2020.

If you have questions about this announcement to discontinue development of the LigandFit engine, please do not hesitate to contact BIOVIA Support:

North America and Europe: biovia.support@3ds.com
Asia and Japan: biovia.jp.support@3ds.com

Thank you for choosing BIOVIA Discovery Studio.

With kind regards,

BIOVIA Discovery Studio Product Team

Resolution:
n/a